Fee schedule includes expansion of Diabetes Prevention Program
An expansion of the Diabetes Prevention Program (DPP), announced July 7 in the... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - July 8, 2016 Category: Endocrinology Source Type: news

What difference would an empagliflozin CVD indication make?
When a Food and Drug Administration advisory committee met on June 28 to consider a new indication for the type 2 diabetes drug empagliflozin – reduction of cardiovascular mortality in patients with... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - July 7, 2016 Category: Endocrinology Source Type: news

Medical errors and the law
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as “bridge” therapy. On day 4, the patient achieved anticoagulation... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - July 7, 2016 Category: Endocrinology Source Type: news

Apologizing for medical errors
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as “bridge” therapy. On day 4, the patient achieved anticoagulation... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - July 7, 2016 Category: Endocrinology Source Type: news

New fragility fracture recommendations emphasize coordination of care
LONDON – The European League Against Rheumatism and the European Federation of National Associations of Orthopaedics and Traumatology have joined forces to develop recommendations for the prevention... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - July 6, 2016 Category: Endocrinology Source Type: news

Cochrane review: Endometrial scratching may promote implantation
HELSINKI, FINLAND – Scratching the endometrium to create a “favorable inflammation” may improve the likelihood of embryo implantation in subfertile women trying to conceive either naturally or by... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - July 6, 2016 Category: Endocrinology Source Type: news

mtDNA level predicts IVF embryo viability
HELSINKI – Mitochondrial DNA level appears to be a useful biomarker for in vitro fertilization embryo viability, according to findings from a blinded prospective non-selection study. An analysis of... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - July 5, 2016 Category: Endocrinology Source Type: news

Pediatric cancer survivors at increased risk for endocrine abnormalities
Patients who survived pediatric-onset cancer are at increased risk for developing or experiencing endocrine abnormalities. Risk was significantly higher in survivors who underwent high-risk... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - July 5, 2016 Category: Endocrinology Source Type: news

Multisite NIH-sponsored research can now use single IRB
In an effort to streamline multisite clinical research, the National Institutes of Health announced a new policy related to the use of institutional review boards (IRBs).   <table... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - July 1, 2016 Category: Endocrinology Source Type: news

In T1D, quality of life measures fall short
NEW ORLEANS – Quality of life measures are sorely lacking for patients with type 1 diabetes, but researchers are attempting to identify measures of patient well-being that go beyond the hemoglobin... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - June 29, 2016 Category: Endocrinology Source Type: news

FDA panel narrowly endorses empagliflozin’s cardiovascular mortality benefit
ROCKVILLE, MD. – In a 12-11 vote, a Food and Drug Administration advisory panel just barely came down in favor of the agency adding a new labeling entry to the already-approved diabetes drug... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - June 29, 2016 Category: Endocrinology Source Type: news

Novel vaccine scores better hepatitis B seroprotection in type 2 diabetes
NEW ORLEANS – An investigational hepatitis B vaccine known as Heplisav-B provided significantly better seroprotection among adults with type 2 diabetes than did a currently licensed vaccine, based on... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - June 29, 2016 Category: Endocrinology Source Type: news

Menopause and cardiovascular risk examined in type 1 diabetes
NEW ORLEANS – Premenopausal women with type 1 diabetes mellitus have a higher cardiovascular risk, compared with their diabetes-free counterparts. Among postmenopausal women, however, those with type... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - June 28, 2016 Category: Endocrinology Source Type: news

Women’s Health Initiative may account for insomnia’s upward trend
DENVER – Much of the rising prevalence of insomnia among U.S. and Canadian adults may be driven by the sharp reduction in the use of hormone replacement therapy following the 2002 report from the... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - June 28, 2016 Category: Endocrinology Source Type: news

Who are the ‘no-shows’ to diabetes education classes?
NEW ORLEANS – Patients with diabetes who failed to show up for diabetes education classes were slightly younger and less likely to be insured, compared with those who attended the classes. Forty-one... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - June 28, 2016 Category: Endocrinology Source Type: news